Table 1.

Sample characteristics and overall treatment outcomes of smokers and non-smokers

	Smokers (N=48)		Non-smokers (N=25)
	Bupropion (N=29)	Placebo (N=19)	Bupropion (N=7)	Placebo (N=18)
Age, mean	35	33	34	36
Gender, % (N)
Male	66%	63%	43%	72%
Female	34%	37%	57%	28%
Ethnicity, % (N)
White	59%	63%	43%	50%
Hispanic	34%	31%	57%	39%
Other	3%	5%	0%	11%
Educational, mean years	12.8	12.5	13.7	13.0
Days of MA use in past month, mean	13a	15	23a	17
Cigarettes per day at baseline	11.4	11.7	-	-
Treatment Outcomes
Days retained, mean	52	49	55	53
End-of-Treatment Abstinence	17%	16%	14%	17%
Treatment Effectiveness Score (mean negative Urine Drug Screens)	4.6	4.8	4.9	4.6

^aGroup difference significant (p<.05)